Related Experiment Videos
Prediction of arrhythmic events in patients following myocardial infarction
1National Heart Hospital, London, England.
Insights
Clinical assessment and noninvasive tests effectively predict arrhythmic events after acute myocardial infarction. Invasive methods offer limited additional value, and optimal high-risk treatment strategies require further study.
Area of Science:
- Cardiology
- Electrophysiology
- Critical Care Medicine
Background:
- Arrhythmic events, including sudden cardiac death and ventricular tachycardia, pose significant risks post-acute myocardial infarction.
- Predicting these events is crucial for timely intervention and improved patient outcomes.
Purpose of the Study:
- To review the efficacy of various techniques in predicting post-acute myocardial infarction arrhythmic events.
- To evaluate the incremental value of different diagnostic methods beyond standard clinical assessment.
Main Methods:
- Review of clinical assessment strategies.
- Analysis of noninvasive tests: Holter monitoring, signal-averaged ECG, autonomic function tests (baroreceptor sensitivity, heart rate variability).
- Evaluation of invasive methods: programmed ventricular stimulation.
Main Results:
- Clinical assessment identifies high-risk patients, but noninvasive tests (ECG, autonomic function) enhance prognostic accuracy, though they are nonspecific.
- Programmed ventricular stimulation results are inconsistent, with invasive methods offering minimal added value over comprehensive noninvasive evaluation.
- Optimal treatment for high-risk individuals remains under investigation, with emerging nonpharmacological options.
Conclusions:
- A combination of thorough clinical assessment and advanced noninvasive testing provides valuable prediction of arrhythmic events after acute myocardial infarction.
- Invasive electrophysiological studies may not significantly improve risk stratification when compared to detailed noninvasive evaluations.
- Further research is needed to establish definitive treatment protocols for high-risk patients, including device-based therapies and ablation.
Abstract:
The value of techniques used to predict arrhythmic events (sudden cardiac death not preceded by reinfarction and spontaneous sustained ventricular tachycardia) after acute myocardial infarction is reviewed. A full clinical assessment allows the detection of patients with major infarction, present in the majority of those suffering arrhythmic events during follow-up. More sophisticated noninvasive tests, including Holter monitoring, and the high gain, signal averaged ECG, add prognostic accuracy to clinical assessment in patients with major infarction but are by themselves nonspecific. Noninvasive assessment of autonomic function from baroreceptor sensitivity analysis and heart rate variability measurement may also provide useful prognostic information. The results of programmed ventricular stimulation studies in patients with recent acute infarction have been contradictory, though many of the disagreements can be explained by methodological differences. At best this technique is highly invasive, and probably adds little to what can be discovered from a thorough noninvasive assessment. The treatment to be adopted in those judged to be at high risk remains to be established, and this may include nonpharmacological modalities such as the implantable defibrillator and surgical ablation as alternatives to drug therapy.